Ledger.Open graph →
SEC Form D · filed December 15, 2009

ACCELERON PHARMA INC

Offering
$11.0M
Sold
$11.0M
Exemption
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

People & firms on this filing (26)

Wylie W. Vale · CAMBRIDGE, MADirectorAnthony B. Evnin · CAMBRIDGE, MADirectorEd Kania · CAMBRIDGE, MADirectorTom W. Maniatis · CAMBRIDGE, MADirectorCarl L. Gordon · CAMBRIDGE, MADirectorPat Gage · CAMBRIDGE, MADirectorMatthew L. Sherman · CAMBRIDGE, MAExecJasbir Seehra · CAMBRIDGE, MAExecJean M. George · CAMBRIDGE, MADirectorRichard F. Pops · CAMBRIDGE, MADirectorTerry Mcguire · CAMBRIDGE, MADirectorJohn Knopf · CAMBRIDGE, MAExec · DirectorPeter Courossi · CAMBRIDGE, MAExecErik Pampalone · Chatsworth, CAExec · DirectorStacey M. Patterson · Chatsworth, CAExecMike Lowe · Santa Cruz, CAExecDavid Turnerr · San Diego, CAExecJohn Montieth · San Diego, CADirectorRobert D. Mitchell · Palo Alto, CADirectorJeffrey Closs · Palo Alto, CADirectorMichael Gertner · Palo Alto, CADirectorGuido Neels · Palo Alto, CADirectorWilliam Nighan · Palo Alto, CADirectorCharles S. Taylor · Palo Alto, CADirectorThomas A. Proulx · San Francisco, CADirectorJed Katz · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗